Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model - PubMed (original) (raw)

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

V G Hemming et al. J Infect Dis. 1985 Nov.

No abstract available

PubMed Disclaimer

Similar articles

• Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys.
  Hemming VG, Prince GA, London WT, Baron PA, Brown R, Chanock RM. Hemming VG, et al. Antimicrob Agents Chemother. 1988 Aug;32(8):1269-70. doi: 10.1128/AAC.32.8.1269. Antimicrob Agents Chemother. 1988. PMID: 3142351 Free PMC article.
• The use of purified immunoglobulin in the therapy of respiratory syncytial virus infection.
  Prince GA, Hemming VG, Chanock RM. Prince GA, et al. Pediatr Infect Dis. 1986 May-Jun;5(3 Suppl):S201-3. Pediatr Infect Dis. 1986. PMID: 3714524 No abstract available.
• Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.
  Prince GA, Hemming VG, Horswood RL, Chanock RM. Prince GA, et al. Virus Res. 1985 Oct;3(3):193-206. doi: 10.1016/0168-1702(85)90045-0. Virus Res. 1985. PMID: 3907188
• Serious respiratory tract disease caused by respiratory syncytial virus: prospects for improved therapy and effective immunization.
  Chanock RM, Parrott RH, Connors M, Collins PL, Murphy BR. Chanock RM, et al. Pediatrics. 1992 Jul;90(1 Pt 2):137-43. Pediatrics. 1992. PMID: 1603639 Review. No abstract available.
• Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.
  McIntosh K, Fishaut JM. McIntosh K, et al. Prog Med Virol. 1980;26:94-118. Prog Med Virol. 1980. PMID: 6999535 Review. No abstract available.

Cited by

• Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
  Elango N, Prince GA, Murphy BR, Venkatesan S, Chanock RM, Moss B. Elango N, et al. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1906-10. doi: 10.1073/pnas.83.6.1906. Proc Natl Acad Sci U S A. 1986. PMID: 3513191 Free PMC article.
• Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.
  Domachowske JB, Rosenberg HF. Domachowske JB, et al. Clin Microbiol Rev. 1999 Apr;12(2):298-309. doi: 10.1128/CMR.12.2.298. Clin Microbiol Rev. 1999. PMID: 10194461 Free PMC article. Review.
• Viral infection of the lung: host response and sequelae.
  Yoo JK, Kim TS, Hufford MM, Braciale TJ. Yoo JK, et al. J Allergy Clin Immunol. 2013 Dec;132(6):1263-76; quiz 1277. doi: 10.1016/j.jaci.2013.06.006. Epub 2013 Aug 1. J Allergy Clin Immunol. 2013. PMID: 23915713 Free PMC article. Review.
• Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.
  Hemming VG. Hemming VG. Clin Diagn Lab Immunol. 2001 Sep;8(5):859-63. doi: 10.1128/CDLI.8.5.859-863.2001. Clin Diagn Lab Immunol. 2001. PMID: 11527792 Free PMC article. Review. No abstract available.
• Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.
  Weltzin R, Hsu SA, Mittler ES, Georgakopoulos K, Monath TP. Weltzin R, et al. Antimicrob Agents Chemother. 1994 Dec;38(12):2785-91. doi: 10.1128/AAC.38.12.2785. Antimicrob Agents Chemother. 1994. PMID: 7695263 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database